×
About 6,865 results

ALLMedicine™ Hypertrophic Cardiomyopathy Center

Research & Reviews  2,585 results

Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
https://doi.org/10.1093/eurheartj/ehab608
European Heart Journal; Elliott P

Sep 14th, 2021 - Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.|2021|Elliott P,|

A very rare cause of mitral regurgitation in hypertrophic cardiomyopathy: the quadricus...
https://doi.org/10.1007/s10554-021-02406-w 10.1016/j.jacc.2016.01.071 10.1016/j.jacc.2016.07.735
The International Journal of Cardiovascular Imaging; Kamperidis V, Karamitsos T et. al.

Sep 14th, 2021 - A very rare cause of mitral regurgitation in hypertrophic cardiomyopathy: the quadricuspid mitral valve.|2021|Kamperidis V,Karamitsos T,Parcharidou D,Efthimiadis G,Karvounis H,|

Stress activated signalling impaired protein quality control pathways in human hypertro...
https://doi.org/10.1016/j.ijcard.2021.09.009
International Journal of Cardiology; Hassoun R, Budde H et. al.

Sep 14th, 2021 - Hypertrophic cardiomyopathy (HCM) is a complex myocardial disorder with no well-established disease-modifying therapy so far. Our study aimed to investigate how autophagy, oxidative stress, inflammation, stress signalling pathways, and apoptosis a...

Hypothyroid cardiomyopathy: A reversible phenocopy of hypertrophic cardiomyopathy.
https://doi.org/10.1111/echo.15183
Echocardiography (Mount Kisco, N.Y.); Cianciulli TF, Morita LA et. al.

Sep 13th, 2021 - We present the case of a 46-year-old patient with hypothyroidism secondary to Hashimoto's thyroiditis who was admitted with decompensation in the form of myxedema. A 2-D echocardiogram shows a septal asymmetric hypertrophy, with low-voltage QRS co...

Hypertrophic Cardiomyopathy in the General Population: Leveraging the UK Biobank Databa...
https://doi.org/10.1016/j.jacc.2021.07.036
Journal of the American College of Cardiology; Baudhuin LM

Sep 11th, 2021 - Hypertrophic Cardiomyopathy in the General Population: Leveraging the UK Biobank Database and Machine Learning Phenotyping.|2021|Baudhuin LM,|

see more →

Guidelines  8 results

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic ca...
https://doi.org/10.1016/j.jtcvs.2021.04.001
The Journal of Thoracic and Cardiovascular Surgery; , Ommen SR et. al.

May 1st, 2021 - 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Ommen SR,Mital S...

ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestatio...
https://doi.org/10.1016/j.jacr.2021.01.019
Journal of the American College of Radiology : JACR; , Rajiah P et. al.

Mar 3rd, 2021 - Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Var...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.045
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 25th, 2020 - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Ommen SR,Mital S,B...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.044
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 25th, 2020 - This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting d...

Guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (JC...
https://doi.org/10.1253/circj.CJ-66-0122
Circulation Journal : Official Journal of the Japanese Ci...

Feb 5th, 2016 - Guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (JCS 2012) - Digest Version .|2016| ,|diagnosis,physiopathology,therapy,

see more →

Drugs  4 results see all →

Clinicaltrials.gov  4 results

A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
https://clinicaltrials.gov/ct2/show/NCT04349072

Sep 8th, 2021 - This is a randomized, double-blind, placebo-controlled, multi-center study in the United States (U.S.) that will evaluate the effect of mavacamten treatment on reducing the number of septal reduction therapy (SRT) procedures performed in subjects ...

Biomarkers in Aortic Stenosis - B.A.S.S.
https://clinicaltrials.gov/ct2/show/NCT01334801

Jul 12th, 2021 - Patients with aortic stenosis, hypertrophic cardiomyopathy, mitral regurgitation, aortic regurgitation, artificial heart valve regurgitation or stenosis, and tricuspid valve regurgitation associated with pacemaker leads who are referred for clinic...

The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT04355260

Jan 15th, 2021 - Objective to investigate the safety and effectiveness of Echocardiography-guided radiofrequency ablation in patients with Hypertrophic obstructive Cardiomyopathy (HOCM). Percutaneous intramyocardial septal radiofrequency ablation (Liwen Procedure)...

Hyp Obst Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT04329689

Apr 1st, 2020 - Hypertrophic Obstructive cardiomyopathy (HOCM) is the most common genetic cardiomyopathy, heterogeneous in phenotype and clinical course. The genotype-phenotype relationship and associated molecular mechanisms are still incompletely understood. In...

see more →

News  137 results

High-Intensity Exercise Safe and Effective in HCM Patients
https://www.medscape.com/viewarticle/952866

Jun 10th, 2021 - Patients with hypertrophic cardiomyopathy (HCM) can not only safely complete a high-intensity exercise programme but experience significant improvements in fitness, cardiovascular risk, and psychological outcomes, say UK researchers. Dr Joyee Basu...

Pathogenic Variants Tied to Unexplained Sudden Cardiac Death in US Adults
https://www.medscape.com/viewarticle/952606

Jun 8th, 2021 - NEW YORK (Reuters Health) - Close to 20% of U.S. adults dying from unexplained sudden cardiac death (SCD) carried pathogenic or likely pathogenic (P/LP) variants of inherited cardiomyopathies (CMs) and arrhythmia syndromes in a large genetic assoc...

Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy
https://www.medscape.com/viewarticle/952563

Jun 7th, 2021 - Of patients with symptomatic, obstructive hypertrophic cardiomyopathy treated with the investigational oral agent mavacamten, more than twice as many, compared with placebo, had a very large improvement from baseline in their summary quality of li...

New HCM Guidelines Make Shared Decision-making Top Priority
https://www.medscape.com/viewarticle/941365

Nov 20th, 2020 - Greater involvement of the patient and family in decision-making, clarity on the role of genetic testing and parameters for team-oriented care, and use of high-volume specialty centers are cornerstones of the first update in almost a decade of the...

Surgery Still Best Option in Obstructive HCM Despite EXPLORER-HCM Results
https://www.medscape.com/viewarticle/939029

Oct 15th, 2020 - Among the landmark presentations at the recent European Society of Cardiology virtual congress was the presentation on the EXPLORER-HCM randomized controlled trial. In this study, simultaneously published in The Lancet, the investigational drug ma...

see more →

Patient Education  8 results see all →